A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fisher Asset Management, LLC holds 227,998 shares of BMY stock, worth $12.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
227,998
Previous 225,753 0.99%
Holding current value
$12.1 Million
Previous $12.2 Million 22.66%
% of portfolio
0.0%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $90,361 - $118,962
2,245 Added 0.99%
227,998 $9.47 Million
Q1 2024

May 09, 2024

BUY
$47.98 - $54.4 $111,409 - $126,316
2,322 Added 1.04%
225,753 $12.2 Million
Q4 2023

Mar 05, 2024

SELL
$48.48 - $57.85 $53,618 - $63,982
-1,106 Reduced 0.49%
223,431 $11.5 Million
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $6.17 Million - $7.36 Million
127,228 Added 130.75%
224,537 $11.5 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $8.58 Million - $9.59 Million
-148,228 Reduced 60.37%
97,309 $5.65 Million
Q2 2023

Dec 12, 2023

BUY
$63.71 - $70.74 $9.42 Million - $10.5 Million
147,884 Added 151.97%
245,193 $15.7 Million
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $2.9 Million - $3.22 Million
45,492 Added 22.74%
245,537 $15.7 Million
Q1 2023

Dec 12, 2023

BUY
$65.71 - $74.53 $7.03 Million - $7.97 Million
106,943 Added 109.9%
204,252 $14.2 Million
Q1 2023

May 01, 2023

BUY
$65.71 - $74.53 $85,751 - $97,261
1,305 Added 0.66%
200,045 $13.9 Million
Q4 2022

Feb 03, 2023

SELL
$68.48 - $81.09 $12.9 Million - $15.3 Million
-189,036 Reduced 48.75%
198,740 $14.3 Million
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $4,943 - $2.92 Million
-38,024 Reduced 8.93%
387,776 $27.6 Million
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $291,278 - $320,799
-4,011 Reduced 0.93%
425,800 $32.8 Million
Q1 2022

May 05, 2022

SELL
$61.48 - $73.72 $807,355 - $968,091
-13,132 Reduced 2.96%
429,811 $31.4 Million
Q4 2021

Feb 02, 2022

BUY
$53.63 - $62.52 $13.5 Million - $15.7 Million
251,210 Added 131.02%
442,943 $27.6 Million
Q3 2021

Oct 26, 2021

BUY
$59.17 - $69.31 $1.07 Million - $1.25 Million
18,040 Added 10.39%
191,733 $11.3 Million
Q2 2021

Jul 27, 2021

SELL
$61.91 - $67.42 $103,080 - $112,254
-1,665 Reduced 0.95%
173,693 $11.6 Million
Q1 2021

Apr 27, 2021

SELL
$59.34 - $66.74 $224,483 - $252,477
-3,783 Reduced 2.11%
175,358 $11.1 Million
Q4 2020

Jan 29, 2021

BUY
$57.74 - $65.43 $219,354 - $248,568
3,799 Added 2.17%
179,141 $11.1 Million
Q3 2020

Nov 10, 2020

BUY
$57.43 - $63.64 $175,678 - $194,674
3,059 Added 1.78%
175,342 $10.6 Million
Q2 2020

Aug 07, 2020

SELL
$54.82 - $64.09 $1.49 Million - $1.74 Million
-27,191 Reduced 13.63%
172,283 $10.1 Million
Q1 2020

Apr 28, 2020

SELL
$46.4 - $67.43 $14.4 Million - $20.9 Million
-309,852 Reduced 60.84%
199,474 $11.1 Million
Q4 2019

Feb 12, 2020

SELL
$49.21 - $64.19 $362,923 - $473,401
-7,375 Reduced 1.43%
509,326 $32.7 Million
Q3 2019

Oct 29, 2019

SELL
$42.77 - $50.71 $74,163 - $87,931
-1,734 Reduced 0.33%
516,701 $26.2 Million
Q2 2019

Jul 30, 2019

SELL
$44.62 - $49.34 $2.58 Million - $2.86 Million
-57,882 Reduced 10.04%
518,435 $23.5 Million
Q1 2019

Apr 22, 2019

BUY
$45.12 - $53.8 $3.71 Million - $4.42 Million
82,239 Added 16.64%
576,317 $27.5 Million
Q4 2018

Jan 25, 2019

SELL
$48.76 - $63.23 $739,445 - $958,882
-15,165 Reduced 2.98%
494,078 $25.7 Million
Q3 2018

Oct 24, 2018

SELL
$55.19 - $62.25 $3.98 Million - $4.49 Million
-72,067 Reduced 12.4%
509,243 $31.6 Million
Q2 2018

Jul 09, 2018

BUY
$50.53 - $62.98 $213,691 - $266,342
4,229 Added 0.73%
581,310 $32.2 Million
Q1 2018

Apr 19, 2018

SELL
$59.92 - $68.98 $307,509 - $354,005
-5,132 Reduced 0.88%
577,081 $36.5 Million
Q4 2017

Jan 24, 2018

BUY
$59.94 - $65.35 $4.66 Million - $5.08 Million
77,720 Added 15.41%
582,213 $35.7 Million
Q3 2017

Oct 17, 2017

BUY
$55.23 - $63.74 $27.9 Million - $32.2 Million
504,493
504,493 $32.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $112B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.